Researchers combine gene therapy with optogenetics to curb abnormal neural activity and prevent seizure-like activity in neurons.

Shares of several COVID-19 vaccine developers sank fast enough to reflect investor jitters about vaccine policy given RFK’s ...

The BiaB advantages over traditional methods of RNA manufacturing, include high throughput of high-quality pharmaceutical ...

Engineered receptors could lead to more precisely targeted, effective cancer therapies with fewer side effects than existing ...

New ML model shows importance of microbial load, as opposed to the more often used microbial composition, as a metric in ...

The amino acid glutamine plays an unexpected role in erythropoiesis, the differentiation of erythroid progenitor cells into ...

Innovative drug development "the flavor of 2025" says Ali Pashazadeh, who discusses how the new administration will likely ...

Results of research in mice may provide potential avenues for therapeutic interventions in stress-related disorders.

Immune-cell therapy shrank children's brain tumors, restored neurologic function and—for one participant—erased all ...

Lonza offers customers a fully integrated solution, spanning design and lead molecule generation, including Synaffix ...

The topline data showed ISM001-055 to have improved the forced vital capacity (FVC) of IPF patients studied 12 weeks after ...

SSPC and NIBRT will use hybrid modeling techniques to improve process development for advanced therapies under new ...